Serum antibodies to the hepatitis a virus in persons following a history of the infection
Prikazchikov, S.A.
Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 72-75
1987
ISSN/ISBN: 0372-9311 PMID: 3033953 Document Number: 298889
Enzyme immunoassay was used for titration of serum antibodies in subjects with a history of clinically pronounced or asymptomatic hepatitis A infection. Titers of hepatitis A virus antibodies (anti-HAV) essentially decreased during 3-4 years after the disease, then the rate of this decrease slowed down and antibody titers stabilized at low levels. After clinically pronounced hepatitis A anti-HAV levels were considerably higher than after the asymptomatic form of this infection.
Document emailed within 1 workday
Related Documents
Boroń, P.; Bobrowska, E.; Borzuchowska, A.; Kaczmarska, A.; Kamińska, H.; Prokopowicz, D.; Szpakowicz, T.; Sidun, Z. 1987: Occurrence of antigens and specific antibodies against hepatitis B virus infection in relation to other immunoserological indicators in alcohol-dependent persons Przeglad Epidemiologiczny 41(3): 311-318El-Sayed, N.M.; el-Halawani, T.A. 1995: Comparative study of serum and salivary hepatitis B surface antigen and hepatitis C antibodies among patients infected with hepatitis B or C virus Egyptian Dental Journal 41(3): 1305-1312
Pazdiora, P.; Herynková, R.; Opatrný, K.; Veselá, E.; Benesová, J.; Vlasák, J.; Vodrázková, Z.; Holá, R.; Kubátová, A.; Hájek, V. 1993: Hepatitis C virus antibodies in persons on dialysis Casopis Lekaru Ceskych 132(8): 243-245
Reed, B.E.; Barrett, A.P.; Smith, M.W. 1986: The prevalence of hepatitis B virus exposure in patients disclosing a past history of hepatitis infection Australian and New Zealand Journal of Medicine 16(2): 237-238
Leone, N.; Rizzetto, M. 2005: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma Minerva Gastroenterologica E Dietologica 51(1): 31-46
Paktoris, E.A.; Trofimova, L.I.; Sergeeva, N.A.; Sinaĭko, G.A.; Shakhgil'dian, I.V. 1979: Antigen e and its antibodies in acute serum hepatitis and in persons with a prolonged HBs-antigenemia Voprosy Virusologii 2: 156-161
Gröticke, J.W.; Gerken, G.; Steinmann, J.; Arnold, W. 1988: Quantitative and qualitative findings of hepatitis B virus-associated antigens, receptors and antibodies in the course of the acute phase of hepatitis B infection Zeitschrift für Gastroenterologie 26(7): 363-373
Mondelli, M.U. 2003: Natural history of hepatitis C virus infection Journal of Biological Regulators and Homeostatic Agents 17(2): 128-132
Eddleston, A.L. 1988: The natural history of hepatitis B virus infection Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(Suppl 3): 5-8
Kozlowski, P.A.; Black, K.P.; Shen, L.; Jackson, S. 1995: High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG Journal of Immunology 154(11): 6163-6173
Fabrizi, F.; Martin, P.; Lunghi, G.; Ponticelli, C. 2003: Natural history of hepatitis C virus infection in dialysis Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 20(5): 470-477
Sansonno, D.E.; Bufano, G.; Fiore, G.; Manghisi, O.G. 1987: Correlation between hepatitis B core antigen in liver tissue and hepatitis B virus DNA in the serum of HBV-infection chronic carriers Archives of Pathology and Laboratory Medicine 111(8): 689-690
Echevarría, J.M.; León, P. 1995: Hepatitis B virus: biology, natural history, and diagnosis of the infection Enfermedades Infecciosas y Microbiologia Clinica 13(Suppl 1): 22-30
Alberti, A.; Pontisso, P.; Chemello, L.; Schiavon, E.; Realdi, G. 1983: Virus receptors for polymerized human serum albumin and anti-receptor antibody in hepatitis B virus infection Progress in Clinical and Biological Research 143: 327-336
Mahmoud, H.S.; Ghweil, A.A.S.; Osman, G.S.; Ezz-Eldin S Bazeed, S.; Helal, M.M. 2016: Correlation between Serum Hyaluronic Acid with Steatosis, Non alcoholic Steato-hepatitis and Fibrosis in Patients with Chronic Hepatitis C Virus Infection Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 37(2): 93-100
Motta, M.; Brischetto, R.; Rapisarda, F.; Corno, C.; Rapisarda, C.; Fatuzzo, P.; Messina, A.; Biondi, A.; Mezzasalma, E.; Calcara, G. 1991: The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 6(4): 375-378
Hewitt, J.; Harte, D.; Sutherland, M.; Croucher, D.; Fouche, L.; Flanagan, P.; Williamson, D. 2018: Prevalence of hepatitis e virus antibodies and infection in New Zealand blood donors New Zealand Medical Journal 131(1469): 38-43
Tàssies, D.; Magallón, M.; Quintana, M.; Fernández-Urgellés, R.P.; Rodriguez-Pinto, C.; Tusell, J.; Altisent, C.; Reverter, J.C.; Mazzara, R.; Ordinas, A.; Monteagudo, J. 1999: Hepatitis G virus infection markers (RNA and anti-E2 antibodies) in a multicenter cohort of hemophiliacs Haematologica 84(10): 930-936
Prilutskiĭ, A.S.; Lysenko, K.L.; Koshkareva, I.N.; Seliverstova, V.G.; Kalimbet, N.V. 2006: Registration rate of IgG antibodies produced against antigens of virus hepatitis G in patients with HIV infection Likars'ka Sprava 2006(7): 17-19
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354